Magenta

Magenta Therapeutics Good News-Bad News Trial Data

November 4, 2018 Paul Knoepfler 0

Magenta Therapeutics is a biotech company with a portfolio including stem cell products. Their most well known investigational drug product is an expanded umbilical cord stem cell product called MGTA-456, an “ex-Novartis” product. Magenta just released new trial data on […]